Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1954 1
1956 1
1961 2
1962 3
1964 1
1968 1
1970 1
1971 1
1974 1
1975 6
1976 2
1977 7
1978 4
1979 4
1980 7
1981 18
1982 29
1983 103
1984 240
1985 300
1986 338
1987 349
1988 368
1989 461
1990 491
1991 520
1992 525
1993 506
1994 449
1995 501
1996 483
1997 527
1998 556
1999 622
2000 710
2001 664
2002 690
2003 699
2004 704
2005 838
2006 846
2007 873
2008 886
2009 897
2010 909
2011 873
2012 945
2013 983
2014 937
2015 994
2016 980
2017 953
2018 954
2019 1040
2020 1077
2021 1181
2022 1168
2023 1092
2024 1113
2025 1202
2026 184

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29,220 results

Results by year

Filters applied: . Clear all
Page 1
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches.
Heymans S, Lakdawala NK, Tschöpe C, Klingel K. Heymans S, et al. Lancet. 2023 Sep 16;402(10406):998-1011. doi: 10.1016/S0140-6736(23)01241-2. Lancet. 2023. PMID: 37716772 Review.
Dilated cardiomyopathy is conventionally defined as the presence of left ventricular or biventricular dilatation or systolic dysfunction in the absence of abnormal loading conditions (eg, primary valve disease) or significant coronary artery disease sufficient to ca
Dilated cardiomyopathy is conventionally defined as the presence of left ventricular or biventricular dilatation or systolic d
Neonatal dilated cardiomyopathy.
Soares P, Rocha G, Pissarra S, Soares H, Flôr-de-Lima F, Costa S, Moura C, Dória S, Guimarães H. Soares P, et al. Rev Port Cardiol. 2017 Mar;36(3):201-214. doi: 10.1016/j.repc.2016.10.007. Epub 2017 Feb 28. Rev Port Cardiol. 2017. PMID: 28256370 Free article. Review. English, Portuguese.
Myocarditis is an important cause and is responsible for the majority of acquired cases. Inherited (familial) forms of dilated cardiomyopathy may occur in 25-50% of patients. Echocardiographic and tissue Doppler studies are the basis for diagnosis of dilated
Myocarditis is an important cause and is responsible for the majority of acquired cases. Inherited (familial) forms of dilated car
Dilated Cardiomyopathy.
Knowlton KU. Knowlton KU. Circulation. 2019 May 14;139(20):2339-2341. doi: 10.1161/CIRCULATIONAHA.119.040037. Circulation. 2019. PMID: 31082299 No abstract available.
Dilated cardiomyopathy.
[No authors listed] [No authors listed] Nat Rev Dis Primers. 2019 May 9;5(1):33. doi: 10.1038/s41572-019-0088-x. Nat Rev Dis Primers. 2019. PMID: 31073134 No abstract available.
Truncations of titin causing dilated cardiomyopathy.
Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE. Herman DS, et al. N Engl J Med. 2012 Feb 16;366(7):619-28. doi: 10.1056/NEJMoa1110186. N Engl J Med. 2012. PMID: 22335739 Free PMC article.
BACKGROUND: Dilated cardiomyopathy and hypertrophic cardiomyopathy arise from mutations in many genes. ...CONCLUSIONS: TTN truncating mutations are a common cause of dilated cardiomyopathy, occurring in approximately 25% of familial cases of idi …
BACKGROUND: Dilated cardiomyopathy and hypertrophic cardiomyopathy arise from mutations in many genes. ...CONCLUSIONS: …
Diagnostic biomarkers of dilated cardiomyopathy.
Moeinafshar A, Yazdanpanah N, Rezaei N. Moeinafshar A, et al. Immunobiology. 2021 Nov;226(6):152153. doi: 10.1016/j.imbio.2021.152153. Epub 2021 Nov 8. Immunobiology. 2021. PMID: 34784575 Review.
BACKGROUND: Dilated cardiomyopathy (DCM) is a condition involving dilation of cardiac chambers, which results in contraction impairment. ...
BACKGROUND: Dilated cardiomyopathy (DCM) is a condition involving dilation of cardiac chambers, which results in contraction i …
Dilated cardiomyopathy: from genes and molecules to potential treatments.
Wang X, Lang Z, Yan Z, Xu J, Zhang J, Jiao L, Zhang H. Wang X, et al. Mol Cell Biochem. 2025 Aug;480(8):4549-4571. doi: 10.1007/s11010-025-05269-0. Epub 2025 Mar 29. Mol Cell Biochem. 2025. PMID: 40155570 Review.
Dilated cardiomyopathy has obvious familial characteristics, and mutations in related pathogenic genes can account for about 50% of patients with dilated cardiomyopathy. The most common genes related to dilated cardiomyopathy include TTN,
Dilated cardiomyopathy has obvious familial characteristics, and mutations in related pathogenic genes can account for about 5
Dilated cardiomyopathy.
Siu SC, Sole MJ. Siu SC, et al. Curr Opin Cardiol. 1994 May;9(3):337-43. doi: 10.1097/00001573-199405000-00012. Curr Opin Cardiol. 1994. PMID: 8049591 Review.
To date, there is no specific treatment for dilated cardiomyopathy. Trials evaluating new inodilators have ended in disappointment. ...At present, the recommended treatment of patients with dilated cardiomyopathy remains identical to that of heart fail …
To date, there is no specific treatment for dilated cardiomyopathy. Trials evaluating new inodilators have ended in disappoint …
Dilated cardiomyopathy.
Burch M, Runciman M. Burch M, et al. Arch Dis Child. 1996 Jun;74(6):479-81. doi: 10.1136/adc.74.6.479. Arch Dis Child. 1996. PMID: 8758121 Free PMC article. Review. No abstract available.
Dilated cardiomyopathy and severe heart failure. An update for pediatricians.
Caviedes Bottner P, Córdova Fernández T, Larraín Valenzuela M, Cruces Romero Presentación de Casos Clínicos P. Caviedes Bottner P, et al. Arch Argent Pediatr. 2018 Jun 1;116(3):e421-e428. doi: 10.5546/aap.2018.eng.e421. Arch Argent Pediatr. 2018. PMID: 29756716 Free article. Review. English, Spanish.
Dilated cardiomyopathy is the main cause of heart failure leading to heart transplant. Its prognosis is variable and depends on the etiology, the patient's age at onset, and the severity. The management of dilated cardiomyopathy is aimed at minimizing
Dilated cardiomyopathy is the main cause of heart failure leading to heart transplant. Its prognosis is variable and depends o
29,220 results
You have reached the last available page of results. Please see the User Guide for more information.